Affordable Access

Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy.

Authors
Type
Published Article
Journal
Journal of neurosurgery
Publication Date
Volume
100
Issue
1
Pages
41–46
Identifiers
PMID: 14743910
Source
Medline
License
Unknown

Abstract

These data indicate that patients with recurrent GBMs who start chemotherapy with a smaller volume (< 10 cm3) of residual disease may have a more favorable response to chemotherapy and a more favorable outcome.

Statistics

Seen <100 times